Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 273 results for "lupin ltd"

Novartis sues Cipla over respiratory drug Onbrez
Rediff.com

Novartis sues Cipla over respiratory drug Onbrez

Novartis said it is partnered with generic drugmaker Lupin Ltd to sell the drug in India Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's price. Cipla, India's fourth-largest drugmaker by revenue, launched its copy of Onbrez in New Delhi in October, citing urgent unmet need for the drug in India. "There is an ample supply of Onbrez, and ... Rediff.com, 1 week ago
[x]  

2 images for "lupin ltd"

Financial Express, 1 month ago
Sify, 1 month ago

Lupin Ltd. (LUPN.BO) Launches Authorized Genericfor Celebrex Capsules 12/11/2014

/PRNewswire/ -- Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the authorized generic for G.D. Searle LLC's (a subsidiary of Pfizer Inc.) Celebrex® Capsules ...
 ClinicSpace2 weeks ago Lupin launches authorized generic for Celebrex Capsule  Moneycontrol.com2 weeks ago Lupin launches generic version of Celebrex in US market  Business Standard India2 weeks ago Lupin Ltd. Launches Authorized Genericfor Celebrex Capsules  BioSpace2 weeks ago
[x]  
Firstpost.com

India extends price caps to 52 more essential drugs

* Drugs include those sold by Lupin, Cadila, Merck Ltd * Regulator says continues work on expanding price control list (Adds comments from NPPA and market research firm) By Zeba Siddiqui MUMBAI, Dec 12 (Reuters) - India has extended price caps to ...
 Yahoo! Finance1 week ago UPDATE 2-India extends price caps to 52 more essential drugs  Reuters1 week ago Govt caps prices of 52 more 'essential' drugs  Business Standard India1 week ago Correction - India caps prices of 52 more "essential" drugs - NPPA  Business Standard India1 week ago
[x]  
Livemint.com

LUPIN : SCOUTING FOR ACQUISITIONS

Lupin Ltd is planning to acquire companies to expand its operations. The company is also planning to launch new products. Lupin has reported revenue of Rs2,479 crore for 2013-2014.
 4 Traders1 week ago LUPIN : DRAWING UP EUROPE ROAD MAP FOR BIO-SIMILAR PRODUCTS  4 Traders1 month ago LUPIN : Scouts for acquisitions in us  4 Traders1 month ago Lupin scouts for acquisitions in US  Livemint.com2 months ago

Lupin explores opportunities for organic and inorganic growth

Earlier Exchange has sought clarification from Lupin Ltd with respect to news article appearing in Economic Times on December 15, 2014 titled "Scouting for Acquisitions" Lupin Ltd clarified that the Company actively explores opportunities for organic and ...
 India Infoline1 week ago LUPIN : TARGETS OVER 20% REVENUE GROWTH  4 Traders1 month ago

Novartis sues Cipla for infringing patents

Comment · print · T T T+· T- TOPICS Swiss drugmaker Novartis AG said on Wednesday it had sued Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's ...
 The Hindu1 week ago

Lupin Appeals Fine Imposed by European Commission in Pay-For-Delay Crackdown

In July of this year, the European Commission imposed fines on French pharmaceutical company Servier and five generic drug makers, including Lupin Ltd., totaling €427.7 million. The fines were the result of a five-year investigation into alleged ...
 JD Supra1 week ago Appeal by Lupin against "pay for delay" decision  Practical Law Company2 weeks ago

Pharmaceutical Newsletter - December 15 to 19, 2014

Lupin Ltd clarified that the Company actively explores opportunities for organic and inorganic growth including acquisitions. Top News Cipla V/s Novartis According to the report, the Delhi high court has reserved its verdict on a dispute between pharma firms ...
 India Infoline6 days ago Merger and Acquisition Round Up - December 15 to 19, 2014  India Infoline6 days ago
Business Standard India

HC reserves order on Novartis-Cipla drug dispute

The dispute is over manufacturing of the drug Indacaterol, used for treatment of chronic obstructive pulmonary disease Press Trust of India | New Delhi December 17, 2014 Last Updated at 20:24 IST The Delhi High Court has reserved its verdict on a ...
 Business Standard India1 week ago Delhi HC reserves order on Novartis-Cipla drug dispute  Livemint.com1 week ago
[x]  

Top 20 intraday trading ideas for rallying mkts

NEW DELHI: After a strong gap-up opening, the S&P BSE Sensex managed to reclaim its crucial psychological level of 27000, after the Cabinet gave its assent to the long-delayed goods and services tax (GST) and recovery in rupee. Tracking the ...
 Economic Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - lupin ltd
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less